Why Exelixis Stock Leaped More Than 4% Higher Today
21/3 00:11
What happened Although share repurchase programs have their detractors, investors tend to like when their companies announce them. This was the dynamic behind biotech stock Exelixis' (NASDAQ: EXEL) more than 4% rise in price on Monday; by contrast, the S&P 500 index rose by "...